Note: This story is part of a series of reports on health tech companies in Finland from a media tour for the technology conference Slush organized and funded by Finnfacts and Tekes — the Finnish Funding Agency for Innovation.
The cutbacks at Nokia in recent years have prompted former staff with mobile hardware and software experience, design and engineering backgrounds to build their own business or help others launch tech startups. One such business is an early stage clinical decision support business for orthopedics based in Helsinki called Disior.
CEO Anna-Maria Henell worked for 15 years creating virtual simulations and modeling systems for technology research and development organizations. A medical adviser for the business, Dr. Risto Kontio is the chairman of the department for Maxillofacial surgery at the University of Helsinki Hospital.
Disior’s software converts medical images into 3D images covered in a mathematical grid that’s designed to help physicians assess fractures and pinpoint whether an implant is needed, where it should be placed, whether it can be minimized and what movement would look like. Physicians can use the interactive D images to optimize the mechanical stress on the bone and the screw interface, as well.
The conversion tool cuts a process that used to take a few weeks down to a few minutes. That could also reduce the risk of a fracture healing before it has to be rebroken, reducing patients’ pain, discomfort, and medical expenses.
The focus has been on wrists, ankles, orbital and facial fractures around the eye and jaw. The technology is intended to be used with augmented reality goggles from Hololens.
Although some hospitals in Finland are working with Disior, Henell is also interested in the much larger U.S. market. Working with the Cambridge Innovation Center and Mass Global Partners, there was a startup boot camp in Helsinki. Henell was one of a handful of health tech and medtech startups to be invited to pitch the company’s technology to Boston hospitals such as Mass General. She said the company’s interactive analysis tools resonated with the hospitals she spoke with there.
Another avenue that the company is interested in exploring is working with larger medtech companies. Yet another possibility would harness the company’s tech for the benefit of training medical school students and surgeons in training.
Download the latest insights from leaders at AstraZeneca, Ipsen, and EMD Serono.
BioEnterprise’s Medical Capital Innovation Competition gives AR/VR/XR startups a shot at $100,000 and co-development opportunities.
You may be interested
Drones Help Bring Back Electricity in Puerto RicoFrank - Apr 20, 2019
Commercial drones are pretty lazy. Think about it: They spend most of their time taking photos and videos, inspecting equipment…
Samsung’s Galaxy S9 Is Photo-Focused and Purple as HeckFrank - Apr 20, 2019
Eager to put the Galaxy Note 7 disaster in the rearview, Samsung used 2017 to double down on impressive, feature-packed…
Healthcare executives voice their top IT priorities for 2018Frank - Apr 20, 2019
A new survey out of the Center for Connected Medicine and the Health Management Academy examines which technologies healthcare executives plan…